Literature DB >> 2828257

Correlation of multiple steroid receptors with histological type and grade in human ovarian cancer.

R Kühnel1, J F Delemarre, B R Rao, J G Stolk.   

Abstract

One hundred eight human ovarian cancers were analyzed for estrogen (ER), progestin (PgR), and androgen (AR) receptors. The receptor levels were related to histological type and grade of the tumor. There were 103 common epithelial carcinomas subdivided into serous (36), endometrioid (36), mucinous (18), clear cell (5), malignant Brenner (3), mixed epithelial (2), and undifferentiated (3) types. Of the remaining five, four were sex cord-stromal tumors and there was a single case of germ cell tumor. ER was detected in 52%, PgR in 52%, and AR in 91% of the cases. There was no correlation between the presence of ER and AR and the tumor histology. The presence of PgR correlated with the grade of endometrioid carcinoma, while no clear correlation existed for the other tumor types. PgR was absent in the three undifferentiated carcinomas. Interestingly, high PgR levels were detected in the three granulosa cell tumors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828257     DOI: 10.1097/00004347-198709000-00006

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  3 in total

1.  Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.

Authors:  Miriam S Butler; Carmela Ricciardelli; Wayne D Tilley; Theresa E Hickey
Journal:  Horm Cancer       Date:  2013-02-27       Impact factor: 3.869

2.  Ovarian sertoliform endometrioid carcinoma.

Authors:  S Remadi; A Ismail; A Tawil; W Mac Gee
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Hormone replacement therapy and survival after surgery for ovarian cancer.

Authors:  R A Eeles; S Tan; E Wiltshaw; I Fryatt; R P A'Hern; J H Shepherd; C L Harmer; P R Blake; C E Chilvers
Journal:  BMJ       Date:  1991-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.